Skip to content

Why your testosterone test came back “normal”: free testosterone levels and what labs miss

Vladimir Kotlov, MD avatar
Vladimir Kotlov, MD: Founder & CEO at Veedma
Nov 09, 2026 · 16 min read

Listen to this article as a podcast episode

June 25, 2026 · 22:15

Yes. A testosterone result can come back “normal” and still miss male hypogonadism when only total testosterone is checked, especially if free testosterone is below 100 pg/mL or testing was not done twice in the morning between 07:00 and 11:00. Broad lab reference ranges, afternoon blood draws, nonfasting samples, and missing LH and FSH are common reasons a symptomatic man is told everything is “fine” when the workup is incomplete.

Find the cause before treating it

Choose a lab panel and get a clinical review with clear next steps.

Order your lab panel

Key takeaways

  • Many labs apply a single adult testosterone reference interval across ages. The harmonized range for total testosterone in healthy nonobese men aged 19 to 39 is 264 to 916 ng/dL.[1] A result inside a lab’s range does not by itself rule out hypogonadism in a symptomatic man.
  • Testosterone is highest in the early morning. In men aged 30 to 40 it was 20% to 25% lower at 16:00 than at 08:00, so an afternoon draw can make a normal man look low.[2]
  • An oral glucose load lowered mean testosterone by about 25%.[3] The Endocrine Society recommends a fasting morning sample, confirmed with a second fasting morning test.[4]
  • Men with normal total testosterone but low calculated free testosterone, a pattern linked to higher SHBG, report more sexual and physical symptoms. This is one reason a testosterone test can look falsely normal.[5]
  • Direct free testosterone immunoassays are unreliable,[6] and an Endocrine Society position statement calls for testosterone assays to be judged on accuracy against known concentrations.[7]
  • LH and FSH must be measured with testosterone. High LH plus low testosterone points to primary hypogonadism, while low or normal LH plus low testosterone points to secondary or functional hypogonadism, and that distinction shapes treatment.[4]

Why a “normal” testosterone reference range can still miss deficiency

A laboratory reference range can label a symptomatic man “normal” even when his result sits near the bottom of a broad adult interval. A value inside the harmonized range can still fall below the total testosterone cut-off used to define late-onset hypogonadism in the European Male Ageing Study.[1] [8]

A reference range is the interval a lab flags as usual for the population it studied. Many local ranges apply one adult interval to men of very different ages, body compositions, and health states. A 2017 Journal of Clinical Endocrinology and Metabolism study by Travison and colleagues found that, after testosterone results from four US and European cohorts were calibrated to a CDC reference method, the 2.5th and 5th percentiles in healthy nonobese men aged 19 to 39 were 264 and 303 ng/dL.[1] Testosterone in nonobese men was also higher than in the cohorts as a whole.[1]

The resulting range of 264 to 916 ng/dL was built to make results comparable across laboratories. It does not decide by itself whether an individual symptomatic man is androgen deficient. According to the European Male Ageing Study (EMAS), published in the New England Journal of Medicine in 2010, late-onset hypogonadism is defined by at least three sexual symptoms with total testosterone below 11 nmol/L (about 320 ng/dL) and free testosterone below 220 pmol/L (64 pg/mL).[8] A man at 300 ng/dL is inside the harmonized range and below the EMAS total testosterone cut-off. A “normal” flag on a lab report often means only that the number is common in a broad population.

Why the standard testosterone reference range is so broad

Most laboratories use one adult interval because it is simple to report, not because it fits every man equally well. Weight, metabolic health, liver status, sleep, and age all influence testosterone. When these variables are pooled into one reference group, the lower boundary of “normal” shifts downward.

This is why a man can hear “your testosterone is normal for your age” and still feel unwell. That comparison often places him among peers who include many men with obesity, insulin resistance, or chronic illness. Being average for that group is not the same as having a healthy endocrine profile.

Why “normal for your age” can still be misleading

The “normal for your age” reassurance is weakest when free testosterone is ignored. Free testosterone is the fraction of testosterone that is not tightly bound to proteins and is available to tissues. With aging, total testosterone declines while SHBG rises, so calculated free testosterone falls more than total testosterone does.[5] In the EMAS cohort, men with normal total but low free testosterone were older and in poorer health than men with both values normal.[5]

Why timing and preparation change normal testosterone levels

Testosterone results depend heavily on when and how the sample was collected.[2] [3] [4]

Diurnal variation is the daily rise and fall of a hormone. Testosterone is highest in the early morning and declines through the day. A 2009 Journal of Clinical Endocrinology and Metabolism study by Brambilla and colleagues, which sampled 66 Boston men aged 30 to 80 at three morning and three afternoon visits, found that testosterone at 16:00 was 20% to 25% lower than at 08:00 in men aged 30 to 40.[2] The difference narrowed to about 10% by age 70.[2]

Morning versus afternoon testing

Timing is one of the most common reasons for a misleading result. In the same study, 17 men who had at least one afternoon value below 300 ng/dL had normal testosterone at every morning visit.[2] Inconsistent timing also makes results hard to compare from one visit to the next, which can hide a man whose morning values are persistently borderline.

According to the Endocrine Society guideline, the initial test should be a fasting morning total testosterone measured with an accurate and reliable assay, and the diagnosis should be confirmed with a repeat fasting morning measurement.[4] A draw taken whenever the patient happens to arrive is less reliable from the start.

Fasting versus nonfasting testing

Food intake changes testosterone too. A 2013 Clinical Endocrinology study by Caronia and colleagues found that a 75 g oral glucose load lowered mean serum testosterone in 74 men by about 25%, and 10 of the 66 men who started in the normal range dropped into the hypogonadal range at one or more time points.[3] The authors concluded that men with low nonfasting testosterone should be retested fasting.[3] A fasting blood draw between 07:00 and 11:00 is the practical standard.

Why one test is not enough

One testosterone value cannot reliably diagnose or exclude hypogonadism, which is why guidelines call for a repeat morning measurement.[4]

Hypogonadism is a clinical syndrome of persistent symptoms plus biochemical testosterone deficiency. According to the Endocrine Society, the diagnosis should be made only in men with symptoms and signs of deficiency and unequivocally and consistently low serum testosterone.[4] A low number alone is not a diagnosis, and symptoms alone are not enough either. Among the many symptoms EMAS examined, only poor morning erections, low sexual desire, and erectile dysfunction had a syndromic association with low testosterone.[8]

Why a single normal or low result can mislead

Sleep loss, psychological stress, heavy exercise, and short term illness can all shift testosterone enough to matter clinically. A single low reading might reflect a bad night or an intercurrent illness. A single normal reading might reflect a better than usual day in a man whose levels are usually low. A symptomatic man with one apparently normal result needs confirmation just as much as a man with one low result, and repeat testing protects against both overdiagnosis and underdiagnosis.

When low testosterone is a consequence, not the primary problem

Acute illness, surgery, hospitalization, severe stress, and even a night of poor sleep can temporarily suppress testosterone. In that setting, a low result may be real but not diagnostic of a chronic endocrine disorder.

The opposite pattern also occurs. A man with obesity, metabolic syndrome, chronic disease, or medication related suppression may test low on repeated occasions, but the low testosterone can still be a consequence of those problems rather than the original disease. This is functional hypogonadism: reversible suppression of an otherwise intact hormone system by obesity, metabolic illness, medications, or systemic disease. For the broader framework, see functional vs organic hypogonadism.

Why free testosterone and the assay matter

A falsely reassuring result often happens when total testosterone is reported without an accurate free testosterone value.[5] [6]

Free testosterone is the portion of circulating testosterone that is not tightly bound to proteins and is available to tissues. SHBG, or sex hormone binding globulin, is a liver protein that binds testosterone tightly and can reduce free testosterone even when total testosterone looks acceptable. As a worked example using the Vermeulen formula,[6] a man with total testosterone of 450 ng/dL, SHBG of 80 nmol/L, and normal albumin has a calculated free testosterone of roughly 50 pg/mL, below the 64 pg/mL cut-off used in EMAS.[8]

Normal total testosterone can hide low free testosterone

A 2016 Journal of Clinical Endocrinology and Metabolism study by Antonio and colleagues analyzed 3,334 men aged 40 to 79 from EMAS and found that the 277 men with normal total but low calculated free testosterone had higher SHBG and LH, reported more sexual and physical symptoms, and had lower hemoglobin and bone ultrasound measures than men with both values normal.[5] Men with low total but normal free testosterone, who were younger, more obese, and had lower SHBG, did not show these features, and the authors concluded that free testosterone should be assessed in men with suspected hypogonadal symptoms.[5] This is the core reason some men say, “My testosterone test is normal but I still have symptoms.”

In a 1999 Journal of Clinical Endocrinology and Metabolism comparison, Vermeulen and colleagues found that free testosterone calculated from total testosterone and SHBG was almost identical to the value measured by equilibrium dialysis across a wide range of SHBG levels.[6] The Endocrine Society guideline recommends obtaining free testosterone by equilibrium dialysis or an accurate formula when total testosterone is near the lower limit of normal or when a condition alters SHBG.[4]

Why testosterone test accuracy depends on the assay

Immunoassay is a common antibody based laboratory method. LC-MS/MS, or liquid chromatography tandem mass spectrometry, identifies hormone molecules directly and is more specific. In a 2007 Endocrine Society position statement, Rosner and colleagues described the pitfalls of testosterone measurement and called for laboratory proficiency testing based on accuracy against known concentrations, not only on agreement with other labs using the same method.[7] In a 2003 Clinical Chemistry comparison against isotope dilution gas chromatography mass spectrometry, Taieb and colleagues found that 10 immunoassays read on average 12% low in samples from men, and 3 of them differed by more than 4 nmol/L on average.[9] The 2017 harmonization study likewise attributed a substantial share of the variation between cohorts to assay differences.[1]

For free testosterone, direct analog immunoassays are less reliable still. In the Vermeulen comparison they returned only a fraction of the equilibrium dialysis value, and that fraction varied with SHBG.[6] A free testosterone result from such an assay can therefore conflict with symptoms, total testosterone, and clinical context.

Testing questionCommon routine approachMore reliable approach
Total testosteroneSingle office draw with a routine assayMorning fasting sample, repeated on a second day, using a reliable method
Free testosteroneNo free testosterone, or a routine direct immunoassayEquilibrium dialysis, or calculation from total testosterone, SHBG, and albumin
Mismatch between symptoms and total testosteroneDismissed as “normal”Review free testosterone, assay method, timing, and repeat testing

Why LH and FSH change the result

LH and FSH show whether a low testosterone result comes from the testes or from reduced signaling to the testes, and that distinction shapes treatment.[4]

LH and FSH are pituitary hormones that signal the testes to produce testosterone and sperm. Without them, primary and secondary hypogonadism cannot be told apart, so a testosterone result without LH and FSH is incomplete.

What LH and FSH tell you

High LH plus low testosterone points to primary hypogonadism: the pituitary is signaling strongly, but the testes are not responding. Low or normal LH plus low testosterone points to secondary or functional hypogonadism, in which the testes may still produce testosterone if signaling improves.

Men with primary hypogonadism generally require TRT because the testes cannot respond adequately to stimulation. In secondary or functional hypogonadism the axis is suppressed rather than destroyed, so treating the underlying cause, or a medication that raises the body’s own LH such as enclomiphene, may restore production. TRT, by contrast, suppresses LH, FSH, and sperm production. The Endocrine Society recommends against starting testosterone therapy in men who are planning fertility in the near term.[4] For the full framework, see primary vs secondary hypogonadism.

PatternLikely meaningWhy it matters
Low testosterone plus high LHPrimary hypogonadismThe testes are failing despite strong signaling. TRT is usually required.
Low testosterone plus low or normal LHSecondary or functional hypogonadismThe testes may still respond. Treating the cause or raising LH, for example with enclomiphene, may be considered.
Normal total testosterone plus low free testosteroneHidden testosterone deficiencyRepeat accurate free testosterone testing before dismissing symptoms.

Why missing LH and FSH leads to the wrong care path

Many men receive only a total testosterone result. Some are told they are fine, even though free testosterone and pituitary signaling were never checked. Others start testosterone without anyone knowing whether their hypogonadism is secondary, which can suppress fertility when an approach that preserves the body’s own signaling might have been suitable.

A complete initial panel pairs total and free testosterone with LH and FSH, and commonly adds estradiol, prolactin, and a CBC with hematocrit. Estradiol is a form of estrogen made in men from testosterone. Prolactin is a pituitary hormone that can suppress testosterone when elevated. CBC, or complete blood count, includes hematocrit, which matters for treatment safety. For a step by step overview, see the complete low testosterone testing guide.

What to do if your testosterone test is normal but symptoms persist

If your testosterone test is normal but symptoms persist, the next step is repeat fasting morning testing that includes free testosterone, LH, and FSH, rather than reassurance based on one total testosterone number.[4] [5]

What to request on repeat testing

If a man has persistent symptoms and suspects a falsely normal result, the workup should go beyond a single repeat total testosterone:

  1. Repeat testing on two separate mornings between 07:00 and 11:00, fasting.
  2. Request total testosterone, free testosterone, LH, FSH, estradiol, prolactin, CBC, and a Comprehensive Metabolic Panel.
  3. If your lab does not measure free testosterone by equilibrium dialysis, ask for SHBG and albumin so free testosterone can be calculated.
  4. Interpret results against reference data from healthy men, not only a generic adult lab interval.
  5. Do not accept “normal for your age” as a final answer if the result was obtained under poor conditions or without LH and FSH.

When to seek specialist review

If primary care is not ordering the right panel, a urologist or endocrinologist can complete the workup.

The next step depends on what the complete panel shows. If repeated testing confirms low testosterone with high LH, the problem is primary and TRT is usually required. If repeated testing confirms low testosterone with low or normal LH, the pattern is secondary or functional, and options that preserve the body’s own testosterone production, including enclomiphene, may be discussed. If the result is repeatedly low during chronic illness, obesity, or medication exposure, the diagnosis may be functional hypogonadism rather than irreversible gland failure.

Myth vs fact

Myth: If the lab marks testosterone “normal,” deficiency is ruled out

Fact: A value inside the harmonized adult range can still be below the EMAS total testosterone cut-off, and men with normal total but low free testosterone have more symptoms of deficiency.[1] [5] [8]

Myth: Any time of day test is good enough

Fact: Testosterone is highest in the morning and was 20% to 25% lower by late afternoon in men aged 30 to 40, so afternoon testing can make a man with normal morning levels look low.[2]

Myth: One normal test means your symptoms are not hormonal

Fact: Testosterone fluctuates with sleep, stress, illness, and day to day biology, and the Endocrine Society calls for repeat morning testing to confirm the diagnosis.[4]

Myth: Total testosterone is all that matters

Fact: Men with normal total testosterone but low free testosterone can still have signs and symptoms of deficiency, and they tend to have higher SHBG.[5]

Myth: LH and FSH are optional extra tests

Fact: Without LH and FSH, primary and secondary hypogonadism cannot be told apart, and that distinction shapes the choice of treatment.[4]

Bottom line

A testosterone test can come back “normal” and still be wrong if the sample was drawn at the wrong time, after food, measured with a weak method, or interpreted without free testosterone and LH and FSH. The clinically meaningful question is whether repeated morning fasting testing shows persistent biochemical deficiency in a symptomatic man, and whether LH and FSH explain where the problem starts. For the full diagnostic and treatment roadmap, see the Low testosterone hub.

Veedma offers testing that includes total and free testosterone measured by LC-MS/MS with LH and FSH, or a review of labs you already have, with results interpreted by licensed providers. When appropriate, treatment is enclomiphene or the enclomiphene plus tadalafil tablet. Enclomiphene is not an FDA-approved drug; it is prescribed after a provider confirms the diagnosis and is compounded by a licensed U.S. pharmacy.

References

  1. Travison TG, Vesper HW, Orwoll E, et al. Harmonized Reference Ranges for Circulating Testosterone Levels in Men of Four Cohort Studies in the United States and Europe. J Clin Endocrinol Metab. 2017;102:1161-1173. PMID: 28324103
  2. Brambilla DJ, Matsumoto AM, Araujo AB, et al. The effect of diurnal variation on clinical measurement of serum testosterone and other sex hormone levels in men. J Clin Endocrinol Metab. 2009;94:907-13. PMID: 19088162
  3. Caronia LM, Dwyer AA, Hayden D, et al. Abrupt decrease in serum testosterone levels after an oral glucose load in men: implications for screening for hypogonadism. Clin Endocrinol (Oxf). 2013;78:291-6. PMID: 22804876
  4. Bhasin S, Brito JP, Cunningham GR, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018;103:1715-1744. PMID: 29562364
  5. Antonio L, Wu FC, O’Neill TW, et al. Low Free Testosterone Is Associated with Hypogonadal Signs and Symptoms in Men with Normal Total Testosterone. J Clin Endocrinol Metab. 2016;101:2647-57. PMID: 26909800
  6. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab. 1999;84:3666-72. PMID: 10523012
  7. Rosner W, Auchus RJ, Azziz R, et al. Position statement: Utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. J Clin Endocrinol Metab. 2007;92:405-13. PMID: 17090633
  8. Wu FC, Tajar A, Beynon JM, et al. Identification of late-onset hypogonadism in middle-aged and elderly men. N Engl J Med. 2010;363:123-35. PMID: 20554979
  9. Taieb J, Mathian B, Millot F, et al. Testosterone measured by 10 immunoassays and by isotope-dilution gas chromatography-mass spectrometry in sera from 116 men, women, and children. Clin Chem. 2003;49:1381-95. PMID: 12881456

Start with a lab panel

Get a clinical review of your results and health history, with an explanation of the decision and next steps in your patient chat. If you are eligible and want treatment, choose a plan and save a card to book a video visit at no extra visit fee. Treatment billing starts only if prescribed.

Order your lab panel

Prefer short video breakdowns? Follow @veedma.men on TikTok for quick, study-backed men's hormone explainers.

Vladimir Kotlov, MD

Vladimir Kotlov, MD: Founder & CEO at Veedma

Vladimir Kotlov, MD is the founder of Veedma. A urologist by training, he led a urology department at a fertility and reproductive clinic where he managed a team of 30+ clinicians and improved IVF outcomes by 24%. He then moved to Silicon Valley and spent five years advising healthtech companies before founding Veedma to help men access evidence-based hormone optimization and fertility care.